159 related articles for article (PubMed ID: 37405413)
1. The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
Skrifvars MB; Luethi N; Bailey M; French C; Nichol A; Trapani T; McArthur C; Arabi YM; Bendel S; Cooper DJ; Bellomo R;
Intensive Care Med; 2023 Jul; 49(7):831-839. PubMed ID: 37405413
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial.
Skrifvars MB; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
J Trauma Acute Care Surg; 2017 Sep; 83(3):449-456. PubMed ID: 28590358
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of erythropoietin in patients with traumatic brain injury: a meta-analysis of randomized controlled trials.
Liu WC; Wen L; Xie T; Wang H; Gong JB; Yang XF
J Neurosurg; 2017 Jul; 127(1):8-15. PubMed ID: 27367243
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis.
Knott RJ; Harris A; Higgins A; Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars MB; Vallance S; Varma D; Wills J; Bellomo R
J Neurotrauma; 2019 Sep; 36(17):2541-2548. PubMed ID: 30907230
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial.
Skrifvars MB; Moore E; Mårtensson J; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
Acta Anaesthesiol Scand; 2019 Feb; 63(2):200-207. PubMed ID: 30132785
[TBL] [Abstract][Full Text] [Related]
6. Association Between Early External Ventricular Drain Insertion and Functional Outcomes 6 Months Following Moderate-to-Severe Traumatic Brain Injury.
Taylor JD; Bailey M; Cooper DJ; French C; Menon DK; Nichol AD; Pisică D; Udy A; Volovici V; Higgins AM
J Neurotrauma; 2024 Jun; 41(11-12):1364-1374. PubMed ID: 38279804
[TBL] [Abstract][Full Text] [Related]
7. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
Trials; 2014 Dec; 15():501. PubMed ID: 25528574
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Cause and Timing of Death and Subgroup Differential Effects of Erythropoietin in the EPO-TBI Study.
Skrifvars MB; French C; Bailey M; Presneill J; Nichol A; Little L; Durantea J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R
J Neurotrauma; 2018 Jan; 35(2):333-340. PubMed ID: 29020866
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of erythropoietin for traumatic brain injury.
Liu M; Wang AJ; Chen Y; Zhao G; Jiang Z; Wang X; Shi D; Zhang T; Sun B; He H; Williams Z; Hu K
BMC Neurol; 2020 Nov; 20(1):399. PubMed ID: 33138778
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.
Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars M; Vallance S; Varma D; Wills J; Bellomo R; ;
Lancet; 2015 Dec; 386(10012):2499-506. PubMed ID: 26452709
[TBL] [Abstract][Full Text] [Related]
12. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
[TBL] [Abstract][Full Text] [Related]
13. Potential Efficacy of Erythropoietin on Reducing the Risk of Mortality in Patients with Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
Liu C; Huang C; Xie J; Li H; Hong M; Chen X; Wang J; Wang J; Li Z; Wang J; Wang W
Biomed Res Int; 2020; 2020():7563868. PubMed ID: 33178833
[TBL] [Abstract][Full Text] [Related]
14. EPO treatment does not alter acute serum profiles of GFAP and S100B after TBI: A brief report on the Australian EPO-TBI clinical trial.
Hellewell SC; Conquest A; Little L; Vallance S; Board J; Bellomo R; Cooper DJ; Morganti-Kossmann MC
J Clin Neurosci; 2020 Jun; 76():5-8. PubMed ID: 32331937
[TBL] [Abstract][Full Text] [Related]
15. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
Rowell SE; Meier EN; McKnight B; Kannas D; May S; Sheehan K; Bulger EM; Idris AH; Christenson J; Morrison LJ; Frascone RJ; Bosarge PL; Colella MR; Johannigman J; Cotton BA; Callum J; McMullan J; Dries DJ; Tibbs B; Richmond NJ; Weisfeldt ML; Tallon JM; Garrett JS; Zielinski MD; Aufderheide TP; Gandhi RR; Schlamp R; Robinson BRH; Jui J; Klein L; Rizoli S; Gamber M; Fleming M; Hwang J; Vincent LE; Williams C; Hendrickson A; Simonson R; Klotz P; Sopko G; Witham W; Ferrara M; Schreiber MA
JAMA; 2020 Sep; 324(10):961-974. PubMed ID: 32897344
[TBL] [Abstract][Full Text] [Related]
16. Applying the Sliding Scale Approach to Quantifying Functional Outcomes Up to Two Years After Severe Traumatic Brain Injury.
Eagle SR; Nwachuku E; Deng H; Okonkwo DO; Elmer J; Pease M
J Neurotrauma; 2024 Jun; 41(11-12):1417-1424. PubMed ID: 37551972
[TBL] [Abstract][Full Text] [Related]
17. Association of Vasopressor Choice with Clinical and Functional Outcomes Following Moderate to Severe Traumatic Brain Injury: A TRACK-TBI Study.
Toro C; Temkin N; Barber J; Manley G; Jain S; Ohnuma T; Komisarow J; Foreman B; Korley FK; Vavilala MS; Laskowitz DT; Mathew JP; Hernandez A; Sampson J; James ML; Goldstein BA; Markowitz AJ; Krishnamoorthy V;
Neurocrit Care; 2022 Feb; 36(1):180-191. PubMed ID: 34341913
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of outcomes in patients with traumatic brain injury at a referral hospital in Tanzania: evidence from a survival analysis.
Elahi C; Rocha TAH; da Silva NC; Sakita FM; Ndebea AS; Fuller A; Haglund MM; Mmbaga BT; Nickenig Vissoci JR; Staton CA
Neurosurg Focus; 2019 Nov; 47(5):E6. PubMed ID: 31675716
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury: A randomized, double blind and controlled clinical trial.
Li ZM; Xiao YL; Zhu JX; Geng FY; Guo CJ; Chong ZL; Wang LX
Clin Neurol Neurosurg; 2016 Nov; 150():80-83. PubMed ID: 27611985
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin to Reduce Mortality in Traumatic Brain Injury: A Post-hoc Dose-effect Analysis.
Gantner DC; Bailey M; Presneill J; French CJ; Nichol A; Little L; Bellomo R; ;
Ann Surg; 2018 Mar; 267(3):585-589. PubMed ID: 28151802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]